Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-04-30

Marine Cyanobacteria as a source for Bioactive (apoptosis modifying) Compounds with potential as Cell Biology reagents and drugs

Objective



Background The present partners - representing European oell biologists, marine (micro)biologists, and chemists - will jointly search for more precise chemical tools (directed against specific enzymes) to control the oell signalling reactions leading to apoptotic (programmed) oell death. Apoptosis is presently one of the most intensely studied biological phenomena, both within basic and applied biosciences.
Specific objectives and expected advances
1 Sampling and growth of marine cyanobacteria from European coast-near seas and extreme polar regions. Sampling will be from coastal areas (Baltic sea, Iberian coast, Norwegian fjords), as well as from more extreme polar regions, including Spitsbergen and certain areas of the Antarctica. Monoculturing will be in sever specialised laboratories (Ia,Ib,IIa,III), large scale growth in two of them (Ia,III). It is expected to obtain enough biomass for initial screening (1lOOg) from a number of microbes, and to obtain kg amounts from at least some relevant cyanobacteria.
2 Extrachon, parhal purification and initial screening for bio-activity. Extracts (some partially purified) will be tested for ability to elicit or protect against apoptotic oell death of a number of normal and malignant oell types, for effects on the cytoskeleton, and for effects on isolated protein kinases and phosphatases known to affect cell function and viability. Such a systematic survey has not been done before, but extrapolation of data from preliminary screening of scattered samples indicate a huge potential for discovery of new activities.
3 Isolation, structure elucidation, and detailed probing of selected bio-active compounds. This will involve scale-up of the initial amount of relevant sample, and of extraction and initial purification procedures, followed by final purification and structure elucidation. The purified compounds will be thoroughly characterised with respect to action on cells and on isolated oell signalling enzymes (key kinases and phosphatases), and for degradation and metabolism.
4 Hemisynthetic modificahon of natural compounds (see above), and detailed probing of the effects of chemical modificahion on biological function and availability. This will serve to characterise the important functional groups of the natural compounds, but mostly to enhance their usefulness as cell biology tools or drug (increased bioavailability, potency, specificity). In the first phase hemisynthesis will be performed for nodularin and certain novel marine microcystins, which are already available in the network. 5 Publication, patenhng, commercialisahon. Scientifically important findings involving new compounds of general interest for cell biology research (modifiers of phosphorylation, cytoskeleton, apoptosis) will generally be sought published rapidly in high-ranking journals.
This will help to create a demand for the novel reagents, which will rapidly be exploited by the partners (notably the SME Ic/Va), with due caution for protection of rights, particularly for compounds with a market potential as medical drugs.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

UNIVERSITY OF BERGEN
EU contribution
No data
Address
19,Aarstadveien 19
5019 BERGEN
Norway

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (6)

My booklet 0 0